N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.
Berger A, Brady NJ, Bareja R, Robinson B, Conteduca V, Augello MA, Puca L, Ahmed A, Dardenne E, Lu X, Hwang I, Bagadion AM, Sboner A, Elemento O, Paik J, Yu J, Barbieri CE, Dephoure N, Beltran H, Rickman DS.
Berger A, et al. Among authors: brady nj.
J Clin Invest. 2019 Jul 1;129(9):3924-3940. doi: 10.1172/JCI127961.
J Clin Invest. 2019.
PMID: 31260412
Free PMC article.